Healthcare · Pharmaceuticals & Biotechnology
The largest companies in the same industry by market cap. This company ranks #55 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.
| Company | Market cap (₹ Cr) | PE (TTM) | ROE | 1Y return | Div. yield | Quality | Valuation | Momentum |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | 427,010 | 143.5 | 13.7% | 7.6% | — | 72 | 8 | 30 |
| Divi's Laboratories Limited | 244,125 | 83.0 | 15.3% | 57.8% | 0.33% | 70 | 4 | 51 |
| Torrent Pharmaceuticals Limited | 161,506 | 77.7 | 12.2% | 35.3% | 0.80% | 56 | 0 | 31 |
| Zydus Lifesciences Limited | 113,616 | 32.6 | 17.3% | 14.5% | 0.09% | 74 | 24 | 84 |
| Cipla Limited | 107,888 | 35.1 | 11.2% | -11.7% | 0.97% | 73 | 29 | 62 |
| Laurus Labs Limited | 106,505 | 122.0 | 17.1% | 128.4% | — | 78 | 24 | 53 |
| Mankind Pharma Limited | 102,382 | 46.9 | 11.7% | 0.9% | — | 68 | 12 | 86 |
| Dr. Reddy's Laboratories Limited | 100,411 | 150.9 | 10.9% | -3.7% | — | 62 | 33 | 71 |
| Sun Pharma Advanced Research Company Limited (this stock) | 6,207 | 3.9 | 116.0% | 45.0% | — | 72 | 75 | 66 |
| Period end | Revenue (₹ Cr) | PBT (₹ Cr) | Net profit (₹ Cr) | Basic EPS |
|---|---|---|---|---|
| June 30, 2026 | 40 | -21 | -21 | ₹ |
| March 31, 2026 | 1,853 | 1,761 | 1,761 | ₹ |
| Dec. 31, 2025 | 8 | -80 | -80 | ₹ |
| Sept. 30, 2025 | 8 | -76 | -76 | ₹ |
| June 30, 2025 | 10 | -52 | -52 | ₹ |
| March 31, 2025 | 27 | -61 | -60 | ₹ |
| Dec. 31, 2024 | 15 | -79 | -80 | ₹ |
| Sept. 30, 2024 | 13 | -107 | -107 | ₹ |
| June 30, 2024 | 17 | -96 | -96 | ₹ |
| March 31, 2024 | 17 | -105 | -106 | ₹ |
| Dec. 31, 2023 | 14 | -100 | -100 | ₹ |
| Sept. 30, 2023 | 21 | -86 | -86 | ₹ |
The detailed income statement is standalone-only: the consolidated feed carries just revenue, PBT and net profit.
| Year ended | Revenue (₹ Cr) | PBT (₹ Cr) | Net profit (₹ Cr) |
|---|---|---|---|
| March 31, 2026 | 1,879 | 1,553 | 1,553 |
| March 31, 2025 | 72 | -343 | -343 |
| March 31, 2024 | 76 | -387 | -387 |
Data unavailable.
| Year ended | Operating (₹ Cr) | Investing (₹ Cr) | Financing (₹ Cr) | Capex (₹ Cr) | Free Cash Flow (₹ Cr) |
|---|---|---|---|---|---|
| March 31, 2026 | -239 | -24 | 261 | 24 | -263 |
| March 31, 2025 | -360 | 158 | 199 | 10 | -371 |
| March 31, 2024 | -429 | 392 | 42 | 27 | -456 |
| Year ended | Total Assets (₹ Cr) | Total Equity (₹ Cr) | Reserves (₹ Cr) | Borrowings, Current (₹ Cr) | Borrowings, Non-current (₹ Cr) | Current Assets (₹ Cr) | Current Liabilities (₹ Cr) | Cash & Equivalents (₹ Cr) | Net Block (₹ Cr) | Inventory (₹ Cr) |
|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | 2,171 | 1,339 | 1,306 | 556 | 0 | 1,862 | 754 | 1 | 85 | 0 |
| March 31, 2025 | 336 | -217 | -249 | 158 | 100 | 26 | 374 | 2 | 99 | 0 |
| March 31, 2024 | — | — | — | — | — | — | — | — | — | — |
